Jian Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jian Chen has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Tunyu Jian
Jiangsu Key Laboratory for Conservation and Utilization of Plant Sciences, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences
18 shared publications - Xiaoqin Ding
Jiangsu Key Laboratory for Conservation and Utilization of Plant Resources, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing, 210014, China.
18 shared publications Han Lv
Nanjing University of Chinese Medicine, Nanjing, 210023, China
17 shared publicationsBingru Ren
Jiangsu Key Laboratory for the Research and Utilization of Plant Resources, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing 210014, China
12 shared publicationsYanan Gai
Jiangsu Key Laboratory for Conservation and Utilization of Plant Resources, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing, 210014, China
11 shared publicationsXiuhua Meng
Jiangsu Key Laboratory for Conservation and Utilization of Plant Resources, Institute of Botany, Jiangsu Province, China; Chinese Academy of Sciences (Nanjing Botanical Garden Memorial Sun Yat-Sen), Nanjing, 210014, China
10 shared publications
Latest Publications
- 12 June 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (12) , 18811-18825
Luteolin ameliorates cigarette smoke-induced chronic obstructive pulmonary disease by modulating gut and lung microbiota and amino acid metabolism in C57Bl/6 mice
Exposure to cigarette smoke (CS) is a potent and major risk factor for chronic obstructive pulmonary disease (COPD). Luteolin (Lut), a flavonoid found in many edible plants, has displayed therapeutic effects on COPD; however, the underlying mechanisms are not well comprehended. In this study, C57Bl/6 J mice were exposed to CS combined with lipopolysaccharide (LPS) to induce COPD. Examination of the levels of inflammatory markers, including TNF-α, IL-1β, IL-6, IL-18, NO, and LPS, revealed that CS exposure caused significant lung injury and inflammatory reactions, while treatment with Lut (50 and 100 mg/kg/day) significantly reversed these trends. 16S rRNA sequencing showed that mice exposed to CS not only decreased the richness and composition of the lung microbiota, but also affected the gut microbiota. Lut treatment increased the richness and modulated the composition. Lut treatment altered the abundance of Pseudomonas, Streptococcus, and Actinomyces in the lung microbiota, as well as Actinobacteria, Helicobacter, and Coprococcus in the gut microbiota. Moreover, targeted metabolomics of amino acids showed seven amino acids, which were significantly altered by Lut, including serine (Ser), threonine (Thr), asparagine (Asn), glutamine (Gln), glutamic acid (Glu), histidine (His), and tyrosine (Tyr). Our study suggests that the protection effect of Lut on CS-induced COPD probably relies on the modulation of gut and lung microbiota and amino acid metabolism.
- 12 June 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (12) , 18811-18825
Luteolin ameliorates cigarette smoke-induced chronic obstructive pulmonary disease by modulating gut and lung microbiota and amino acid metabolism in C57Bl/6 mice
Exposure to cigarette smoke (CS) is a potent and major risk factor for chronic obstructive pulmonary disease (COPD). Luteolin (Lut), a flavonoid found in many edible plants, has displayed therapeutic effects on COPD; however, the underlying mechanisms are not well comprehended. In this study, C57Bl/6 J mice were exposed to CS combined with lipopolysaccharide (LPS) to induce COPD. Examination of the levels of inflammatory markers, including TNF-α, IL-1β, IL-6, IL-18, NO, and LPS, revealed that CS exposure caused significant lung injury and inflammatory reactions, while treatment with Lut (50 and 100 mg/kg/day) significantly reversed these trends. 16S rRNA sequencing showed that mice exposed to CS not only decreased the richness and composition of the lung microbiota, but also affected the gut microbiota. Lut treatment increased the richness and modulated the composition. Lut treatment altered the abundance of Pseudomonas, Streptococcus, and Actinomyces in the lung microbiota, as well as Actinobacteria, Helicobacter, and Coprococcus in the gut microbiota. Moreover, targeted metabolomics of amino acids showed seven amino acids, which were significantly altered by Lut, including serine (Ser), threonine (Thr), asparagine (Asn), glutamine (Gln), glutamic acid (Glu), histidine (His), and tyrosine (Tyr). Our study suggests that the protection effect of Lut on CS-induced COPD probably relies on the modulation of gut and lung microbiota and amino acid metabolism.
- 17 February 2026
- Published by Wiley in Journal of Integrative Plant Biology
- Vol. 68 (5) , 1469-1490
N‐glycosylation profiles of apoplast nanoparticles modulate plant immune responses to different pathogens in Arabidopsis
Plants are constantly challenged by diverse pathogens and respond through multilayered immune mechanisms described by the classical “zig‐zag” model. Apoplast nanoparticles (ANs), extracellular vesicle (EV)‐like entities, are dynamically remodeled during plant–pathogen interactions. Although EVs are known to carry immune‐regulatory cargos, the specificity and coordination of ANs protein responses to distinct pathogens remain largely unresolved. Here, we show that the glycosylation profiles of ANs and their N‐glycoproteins undergo distinct remodeling upon infection with Pseudomonas syringae and Botrytis cinerea , as revealed by lectin microarray and mass spectrometry analyses. We identify SPILR, an ANs protein that modulates bacterial morphology and motility by reducing polygalacturonase activity and inhibiting the bacterial flagellar P‐ring protein, FlgI. Additionally, the ESM1 protein enhances Arabidopsis resistance to B. cinerea through modulation of lipase activity and lipid metabolism. Disruption of N‐glycosylation sites on ANs proteins compromises their antimicrobial function and alters host resistance to both bacterial and fungal pathogens. Together, our findings uncover N‐glycosylation as a critical determinant of ANs‐mediated extracellular immunity, highlighting glycosylation as an integrative mechanism linking vesicle biology, pathogen specificity, and immune signaling. This work establishes a framework for glycoengineering‐based strategies to enhance crop resistance and advance nano‐agricultural applications.
- 17 February 2026
- Published by Wiley in Journal of Integrative Plant Biology
- Vol. 68 (5) , 1469-1490
N‐glycosylation profiles of apoplast nanoparticles modulate plant immune responses to different pathogens in Arabidopsis
Plants are constantly challenged by diverse pathogens and respond through multilayered immune mechanisms described by the classical “zig‐zag” model. Apoplast nanoparticles (ANs), extracellular vesicle (EV)‐like entities, are dynamically remodeled during plant–pathogen interactions. Although EVs are known to carry immune‐regulatory cargos, the specificity and coordination of ANs protein responses to distinct pathogens remain largely unresolved. Here, we show that the glycosylation profiles of ANs and their N‐glycoproteins undergo distinct remodeling upon infection with Pseudomonas syringae and Botrytis cinerea , as revealed by lectin microarray and mass spectrometry analyses. We identify SPILR, an ANs protein that modulates bacterial morphology and motility by reducing polygalacturonase activity and inhibiting the bacterial flagellar P‐ring protein, FlgI. Additionally, the ESM1 protein enhances Arabidopsis resistance to B. cinerea through modulation of lipase activity and lipid metabolism. Disruption of N‐glycosylation sites on ANs proteins compromises their antimicrobial function and alters host resistance to both bacterial and fungal pathogens. Together, our findings uncover N‐glycosylation as a critical determinant of ANs‐mediated extracellular immunity, highlighting glycosylation as an integrative mechanism linking vesicle biology, pathogen specificity, and immune signaling. This work establishes a framework for glycoengineering‐based strategies to enhance crop resistance and advance nano‐agricultural applications.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 17 (14) , 6405-6424
Blueberry anthocyanin-pretreated Akkermansia muciniphila enhances probiotic efficacy against metabolic syndrome via gut microbiota remodeling and hepatic signaling modulation
Ameliorative effects of AA on metabolic syndrome mice and its underlying mechanisms.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 17 (14) , 6405-6424
Blueberry anthocyanin-pretreated Akkermansia muciniphila enhances probiotic efficacy against metabolic syndrome via gut microbiota remodeling and hepatic signaling modulation
Ameliorative effects of AA on metabolic syndrome mice and its underlying mechanisms.
- Open Access
- 29 July 2025
- Published by Springer Nature in npj Science of Food
- Vol. 9 (1) , 158
Anthocyanins from blueberry and blackberry ameliorate metabolic syndrome by Prevotella histicola and acetic acid
Metabolic syndrome (MetS) is a globally prevalent disorder and poses a significant threat to human health and social harmony. Consumption of anthocyanins has been proven to improve disrupted gut microbiota and obesity in mice and humans. However, the potential specific gut microbiota and metabolites that might mediate these beneficial effects on MetS remain unknown. Here, the MetS-mice model, induced by a high-fat diet (HFD), was employed to investigate the specific effects of ACNs. Additionally, 16S rRNA sequencing and targeted metabolomics analysis of short-chain fatty acids (SCFAs) were utilized to evaluate the influence on gut microbiota composition and SCFAs levels. More importantly, we also utilized antibiotics to construct a pseudo-germ-free mouse model for fecal microbiota transplantation (FMT) to further confirm the regulation of gut microbiota by ACNs and demonstrating that the related effects on MetS could be transferable through FMT. Our data demonstrated that the amelioration of MetS by ACNs might be achieved through modulation of the gut microbiota, which was validated through FMT, and the related benefits could be transferable by FMT. Furthermore, acetic acid and Prevotella histicola might be key microbial metabolites and bacteria, respectively, in this process. These findings highlight the diet-gut-metabolites-diseases system crosstalk and provide new research perspectives for plant-derived ingredients with poor bioavailability.
- 29 July 2025
- Published by Springer Nature in npj Science of Food
- Vol. 9 (1) , 158
Open AccessAnthocyanins from blueberry and blackberry ameliorate metabolic syndrome by Prevotella histicola and acetic acid
Metabolic syndrome (MetS) is a globally prevalent disorder and poses a significant threat to human health and social harmony. Consumption of anthocyanins has been proven to improve disrupted gut microbiota and obesity in mice and humans. However, the potential specific gut microbiota and metabolites that might mediate these beneficial effects on MetS remain unknown. Here, the MetS-mice model, induced by a high-fat diet (HFD), was employed to investigate the specific effects of ACNs. Additionally, 16S rRNA sequencing and targeted metabolomics analysis of short-chain fatty acids (SCFAs) were utilized to evaluate the influence on gut microbiota composition and SCFAs levels. More importantly, we also utilized antibiotics to construct a pseudo-germ-free mouse model for fecal microbiota transplantation (FMT) to further confirm the regulation of gut microbiota by ACNs and demonstrating that the related effects on MetS could be transferable through FMT. Our data demonstrated that the amelioration of MetS by ACNs might be achieved through modulation of the gut microbiota, which was validated through FMT, and the related benefits could be transferable by FMT. Furthermore, acetic acid and Prevotella histicola might be key microbial metabolites and bacteria, respectively, in this process. These findings highlight the diet-gut-metabolites-diseases system crosstalk and provide new research perspectives for plant-derived ingredients with poor bioavailability.
- 9 May 2025
- Published by Elsevier in Carbohydrate Polymers
- Vol. 363, 123727
Isolation and structural identification of the homogeneous polysaccharide CGPA1 from Calvatia gigantea with wound healing effects
- 9 May 2025
- Published by Elsevier in Carbohydrate Polymers
- Vol. 363, 123727
Isolation and structural identification of the homogeneous polysaccharide CGPA1 from Calvatia gigantea with wound healing effects
- 21 March 2025
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 141, 109908
Benefits of inulin and fructo-oligosaccharides on high fat diet-induced type 2 diabetes mellitus by regulating the gut microbiota in mice
- 21 March 2025
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 141, 109908
Benefits of inulin and fructo-oligosaccharides on high fat diet-induced type 2 diabetes mellitus by regulating the gut microbiota in mice
- 11 February 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (5) , 1830-1846
Amelioration of metabolic syndrome in high-fat diet-fed mice by total sesquiterpene lactones of chicory via modulation of intestinal flora and bile acid excretion
Chicory ( Cichorium intybus L.) is a vegetable with medicinal uses and contains many sesquiterpene lactone compounds which could serve as potential candidates for the prevention and therapeutic intervention of metabolic syndrome.
- 11 February 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (5) , 1830-1846
Amelioration of metabolic syndrome in high-fat diet-fed mice by total sesquiterpene lactones of chicory via modulation of intestinal flora and bile acid excretion
Chicory ( Cichorium intybus L.) is a vegetable with medicinal uses and contains many sesquiterpene lactone compounds which could serve as potential candidates for the prevention and therapeutic intervention of metabolic syndrome.
- Open Access
- 20 November 2024
- Published by Elsevier in Pharmacological Research
- Vol. 210, 107511
Effect of anthocyanins on metabolic syndrome through interacting with gut microbiota
- 20 November 2024
- Published by Elsevier in Pharmacological Research
- Vol. 210, 107511
Open AccessEffect of anthocyanins on metabolic syndrome through interacting with gut microbiota
- 28 May 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 136, 112359
Site-specific pegylated IL2 mutein with biased IL2 receptor binding for cancer immunotherapy
- 28 May 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 136, 112359
Site-specific pegylated IL2 mutein with biased IL2 receptor binding for cancer immunotherapy